View in EDS PDF Full Text

Klinička značajnost otkrivanja mutacije T31 51 u domeni ABL kinaze kod bolesnika rezistentnih na liječenje imatinib mesilatom.

Saved in:
Bibliographic Details
Title: Klinička značajnost otkrivanja mutacije T31 51 u domeni ABL kinaze kod bolesnika rezistentnih na liječenje imatinib mesilatom.
Alternate Title: Clinical significance of T3151 ARL kinase domain mutation detection in patients resistant to imatinib mesylate therapy.
Authors: Horvat, Ivana1, AntoIic, Margareta Radic2, Zadro, Renata2 rzadro@mef.hr, Sertic, Dubravka3, Labar, Boris3
Source: Biochemia Medica. 2010, Vol. 20 Issue 1, p75-81. 7p. 1 Diagram, 2 Charts, 1 Graph.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 49313492
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Klinička značajnost otkrivanja mutacije T31 51 u domeni ABL kinaze kod bolesnika rezistentnih na liječenje imatinib mesilatom.
– Name: TitleAlt
  Label: Alternate Title
  Group: TiAlt
  Data: Clinical significance of T3151 ARL kinase domain mutation detection in patients resistant to imatinib mesylate therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Horvat%2C+Ivana%22">Horvat, Ivana</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22AntoIic%2C+Margareta+Radic%22">AntoIic, Margareta Radic</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Zadro%2C+Renata%22">Zadro, Renata</searchLink><relatesTo>2</relatesTo><i> rzadro@mef.hr</i><br /><searchLink fieldCode="AR" term="%22Sertic%2C+Dubravka%22">Sertic, Dubravka</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Labar%2C+Boris%22">Labar, Boris</searchLink><relatesTo>3</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Biochemia+Medica%22">Biochemia Medica</searchLink>. 2010, Vol. 20 Issue 1, p75-81. 7p. 1 Diagram, 2 Charts, 1 Graph.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=49313492
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 75
    Titles:
      – TitleFull: Klinička značajnost otkrivanja mutacije T31 51 u domeni ABL kinaze kod bolesnika rezistentnih na liječenje imatinib mesilatom.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Horvat, Ivana
      – PersonEntity:
          Name:
            NameFull: AntoIic, Margareta Radic
      – PersonEntity:
          Name:
            NameFull: Zadro, Renata
      – PersonEntity:
          Name:
            NameFull: Sertic, Dubravka
      – PersonEntity:
          Name:
            NameFull: Labar, Boris
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2010
              Type: published
              Y: 2010
          Identifiers:
            – Type: issn-print
              Value: 13300962
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Biochemia Medica
              Type: main
ResultId 1